It would be interesting to see the effect microRNA495 has on other models of PKIB, such as Gerhard’s study highlighting PKIB as a potential biomarker for early breast, lung, ovarian, and colorectal cancers [31]. The gene discussed is PKIB; the disease is colorectal cancer.